← Back to Search

Behavioral Intervention

Cognitive-behavioral therapy for Body Dysmorphic Disorder

N/A
Waitlist Available
Led By Angela Fang, Ph.D.
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Men and women, age 18-45
For patients: treatment-seeking individuals presenting with at least moderate levels of social anxiety/body dysmorphic symptoms, and a score of at least 1 SD above the mean on the public self-consciousness scale of the Self-Consciousness Scale- Revised
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 12 weeks later
Awards & highlights

Study Summary

This study is evaluating whether neuroimaging-based markers of maladaptive self-focused processing are better predictors of treatment response to cognitive-behavioral therapy than behavioral markers.

Eligible Conditions
  • Body Dysmorphic Disorder
  • Social Anxiety Disorder

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 12 weeks later
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 12 weeks later for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from baseline clinical symptoms at 12 weeks
Neural activation in the default mode network
Response latencies during Self vs. Other conditions
+1 more
Secondary outcome measures
Structural connectivity within the default mode network
Word valence during Self vs. Other conditions

Trial Design

1Treatment groups
Experimental Treatment
Group I: Cognitive-behavioral therapyExperimental Treatment1 Intervention
Twelve weekly sessions of individual cognitive-behavioral therapy
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive-behavioral therapy
2012
Completed Phase 4
~2450

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,918 Previous Clinical Trials
13,192,746 Total Patients Enrolled
Angela Fang, Ph.D.Principal InvestigatorUniversity of Washington
1 Previous Clinical Trials
41 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~11 spots leftby Mar 2025